×
About 33 results
MORPHABOND™ ER (morphine sulfate) Prescribing Information
https://dsi.com/prescribing-information-portlet/getPIContent?productName=Morphabond&inline=true

Nov 30th, 2018 - MORPHABOND ER is an opioid agonist indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

ROXYBOND (oxycodone hydrochloride) Prescribing Information
https://dsi.com/prescribing-information-portlet/getPIContent?productName=Roxybond&inline=true

Nov 30th, 2018 - ROXYBOND is an opioid agonist indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

MORPHABOND ER Medication Guide
https://dsi.com/prescribing-information-portlet/getPIContent?productName=Morphabond%20Med&inline=true

May 31st, 2018 - MORPHABOND ER is: A strong prescription pain medicine that contains an opioid (narcotic) that is used to manage pain severe enough to require daily around-the clock, long-term treatment with an opioid, when other pain treatments such as non-opioid pain medicines or immediate-release opioid medicines do not treat your pain well enough or you cannot tolerate them.

ROXYBOND (oxycodone hydrochloride) Medication Guide
https://dsi.com/prescribing-information-portlet/getPIContent?productName=Roxybond_Med&inline=true

Mar 31st, 2017 - ROXYBOND is: A strong prescription pain medicine that contains an opioid (narcotic) that is used to manage pain severe enough to require an opioid pain medicine, when other pain treatments such as nonopioid pain medicines do not treat your pain well enough or you cannot tolerate them.

MORPHABOND (morphine sulfate) extended-release tablets Prescribing Information
http://inspiriondt.com/wp-content/uploads/2012/08/MorphaBond-PI-02Oct2015.pdf

Oct 30th, 2015 - Assess each patient's risk for opioid addiction, abuse, or misuse prior to prescribing MORPHABOND, and monitor all patients receiving MORPHABOND for development of these behaviors or conditions. ... Although the risk of addiction in any individual is unknown, it can occur in patients appropriately prescribed MORPHABOND.

ROXYBOND (oxycodone hydrochloride) tablets Prescribing Information
http://inspiriondt.com/wp-content/uploads/2012/08/RoxyBond-Package-Insert-20Apr17.pdf

Oct 30th, 2015 - ROXYBOND™ safely and effectively. See full prescribing information for ROXYBOND. ROXYBOND (oxycodone hydrochloride) tablets, for oral use, CII.

ACTIQ® (fentanyl citrate
http://www.actiq.com/

INDICATIONS AND USAGE. ACTIQ® oral transmucosal lozenge, CII is indicated for the management of breakthrough pain in cancer patients 16 years of age

BELBUCA® (buprenorphine) buccal film
https://www.belbuca.com/hcp/

BELBUCA® (Buprenorphine) is the first oral formulation of buprenorphine proven to deliver consistent analgesia and tolerability. Rethink Relief.

CASSIPA (buprenorphine and naloxone) sublingual film Prescribing Information
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208042s000lbl.pdf

CASSIPA film contains buprenorphine, a partial‐opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence.

NARCAN NASAL SPRAY
https://www.narcan.com/healthcare-professional

Information for prescribers about the organizations and Surgeon General advice to co-prescribe naloxone to patients who will have opioids. Also includes the Surgeon General’s speech on opioids and co-prescribing naloxone.

BUTRANS® (buprenorphine) TRANSDERMAL SYSTEM
https://butrans.com/

Discover Butrans, a Schedule III, extended-release opioid. See Full Prescribing Info, Safety Info & Boxed Warning.

Embeda® (morphine sulfate and naltrexone hydrochloride) Extended-Release capsules for oral use CII
https://www.pfizerpro.com/product/embeda/hcp

Instruct patients not to consume alcoholic beverages or use prescription or non-prescription products that contain alcohol while taking EMBEDA.

NUCYNTA® ER (tapentadol)
http://www.nucynta.com/

Information for physicians about an analgesic therapy that treats multiple sources of pain. Please see Full Prescribing Information and Important Safety Information.

HYSINGLA ER® (hydrocodone bitartrate) TABLETS
https://hysinglaer.com/

Discover Hysingla ER Extended-Release Tablets CII, a non-APAP hydrocodone. See Full PI, Medication Guide & Boxed Warning.

LUCEMYRA (lofexidine)
https://www.lucemyra.com/

LUCEMYRA (lofexidine), an oral tablet, is a central alpha 2-adrenergic agonist that reduces the release of norepinephrine to suppress the neurochemical surge that produces opioid withdrawal.

KADIAN® (morphine sulfate) extended-release capsules, for oral use, CII
http://www.kadian.com/

Kadian. The U.S. Prescribing Information in this product database represents the current product labeling information as of the date of the document. While every ...

AVINZA® (morphine sulfate extended release)
https://www.pfizer.com/products/product-detail/avinza

AVINZA is an opioid agonist indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which ...

PERCOCET® (oxycodone acetominophen tablets)
http://camberpharma.com/products/oxycodone-acetaminophen

Prolonged use of PERCOCET during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts. If opioid use is required for a prolonged period in a pregnant woman, advise ...

OXYCONTIN® (oxycodone hydrochloride) TABLETS
https://www.oxycontin.com/index.html

OxyContin carries a Boxed Warning and contains oxycodone, a Schedule II controlled substance with an abuse potential similar to other Schedule II opioids.

XTAMPZA ER (oxycodone)
http://www.xtampzaer.com/hcp/index.html

Xtampza® ER (oxycodone) is an extended-release opioid with a proprietary abuse-deterrent technology indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

PURDUE PHARMA/SHIONOGI PHARMA OPIOIDS TREATMENT
http://www.purduepharma.com/healthcare-professionals/responsible-use-of-opioids/

For many years, Purdue has been an industry leader in the fight against opioid abuse and diversion. We are also committed to supporting healthcare professionals on the responsible use of our products.

SYMPROIC® (naldemedine)
https://www.symproic.com/hcp/

Learn about a treatment for opioid-induced constipation in adult patients with chronic non-cancer pain. See Full Prescribing Safety Information.

VIVITROL (naltrexone for extended-release injectable suspension) INJECTION
https://www.vivitrolhcp.com/

VIVITROL® (naltrexone for extended-release injectable suspension) with counseling may help alcohol or opioid dependence. See risks & benefits.

TARGINIQ ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets) Prescribing Information
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205777lbl.pdf

TARGINIQ ER is a combination product consisting of oxycodone, an opioid agonist, and naloxone, an opioid antagonist, indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate

XARTEMIS XR (oxycodone hydrochloride and acetaminophen) Prescribing Information
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204031s000lbl.pdf

XARTEMIS XR (oxycodone hydrochloride and acetaminophen) Extended-Release Tablets is a combination of oxycodone, an opioid agonist, and acetaminophen, and is indicated for the management of acute pain severe enough to require opioid treatment and for which alternative treatment options are inadequate.

MORPHABOND ER™ (morphine sulfate)
https://morphabondhcp.com/
Daiichi Sankyo

Learn about MORPHABOND ER™ (morphine sulfate), a long-acting opioid indicated for chronic pain. See Full Prescribing & Safety Information

Clonidine hci - clonidine hci injection, solution-HF Acquisition Co LLC, DBA HealthFirst
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7daa1996-ea9f-2576-e053-2991aa0a6be5

Feb 6th, 2020 - Clonidine hydrochloride is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone. Epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain (see CLINICAL PHARMACOLOGY: Clinical Trials). The safety of this drug product has only been established in...

Clonidine - clonidine injection, solution-X-GEN Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ada02f1f-ae78-4435-879e-492ae862d504

Jan 29th, 2020 - Clonidine Hydrochloride Injection is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone. Epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain (see Clinical Trials ). The safety of this drug product has only been established in a highly se...

Clonidine hydrochloride - clonidine hydrochloride injection, solution-Cadila Healthcare Limited
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2b11e61-b2ef-4d20-8973-a4afc6b951ae

Dec 18th, 2019 - Clonidine hydrochloride injection is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone. Epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain (see Clinical Trials). The safety of this drug product has only been established in a highly sel...

Clonidine hydrochloride - clonidine hydrochloride injection, solution-Zydus Pharmaceuticals (USA) Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f01f281d-c7e5-4258-ab14-3685f1ff296f

Dec 18th, 2019 - Clonidine hydrochloride injection is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone. Epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain (see Clinical Trials). The safety of this drug product has only been established in a highly sel...

Clonidine hydrochloride - clonidine hydrochloride injection, solution-West-Ward Pharmaceuticals Corp
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2a5b46ec-4c16-48a5-9e58-8d28a3f21274

Dec 12th, 2018 - Clonidine hydrochloride is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone. Epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain (see CLINICAL PHARMACOLOGY: Clinical Trials). The safety of this drug product has only been established in...

Duraclon - clonidine hydrochloride injection, solution-Mylan Institutional LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c126bb8-732a-4949-8754-2f50b5543638

Apr 17th, 2018 - Duraclon is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone. Epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain (see Clinical Trials ). The safety of this drug product has only been established in a highly selected group of cancer pa...

Clonidine hydrochloride - clonidine hydrochloride injection, solution-American Regent, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6798f73-b5a6-434b-a627-aa102b123dd5

Nov 14th, 2016 - Clonidine hydrochloride is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone. Epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain (seeCLINICAL PHARMACOLOGY, Clinical Trials). The safety of this drug product has only been established in ...